Actively Recruiting
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
Led by Boston Medical Center · Updated on 2025-12-01
50
Participants Needed
1
Research Sites
265 weeks
Total Duration
On this page
Sponsors
B
Boston Medical Center
Lead Sponsor
N
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central venous stenosis (CVS) and affects number of patients on hemodialysis in the United States and can compromise the dialysis efficacy. The current diagnostic modality for CVS is venography, which has several limitations. This study proposes to examine intravenous ultrasound (IVUS) as a potentially superior modality, which will provide additional information.
CONDITIONS
Official Title
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with end stage renal disease (ESRD) at Boston Medical Center
- Receiving hemodialysis
- Have a malfunctioning dialysis access
- Undergoing a diagnostic fistulogram for dialysis access malfunction
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boston Medical Center
Boston, Massachusetts, United States, 02118
Actively Recruiting
Research Team
V
Vipul Chitalia, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here